標(biāo)題: Titlebook: Circulating Tumor Cells in Breast Cancer Metastatic Disease; Roberto Pi?eiro Book 2020 Springer Nature Switzerland AG 2020 circulating tum [打印本頁] 作者: 關(guān)稅 時(shí)間: 2025-3-21 19:08
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease影響因子(影響力)
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease影響因子(影響力)學(xué)科排名
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease網(wǎng)絡(luò)公開度
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease被引頻次
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease被引頻次學(xué)科排名
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease年度引用
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease年度引用學(xué)科排名
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease讀者反饋
書目名稱Circulating Tumor Cells in Breast Cancer Metastatic Disease讀者反饋學(xué)科排名
作者: mitral-valve 時(shí)間: 2025-3-21 22:43
Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis,s of metastasis. They exhibit dynamic oscillations in epithelial to mesenchymal plasticity and provide important opportunities for prognosis, therapy response monitoring, and targeting of metastatic disease. In this manuscript, we review the involvement of epithelial-mesenchymal plasticity in the ea作者: blithe 時(shí)間: 2025-3-22 00:53 作者: 協(xié)奏曲 時(shí)間: 2025-3-22 05:34
Methodology for the Isolation and Analysis of CTCs,ast cancer mortality. Currently, liquid biopsies are gaining attention in this regard. Circulating tumor cells (CTCs), an important component of liquid biopsies, are cells shed from primary tumor that disseminate to blood circulation being responsible of distal metastasis. Hence, the study CTCs is a作者: 激怒某人 時(shí)間: 2025-3-22 11:45 作者: 后退 時(shí)間: 2025-3-22 13:01 作者: 后退 時(shí)間: 2025-3-22 20:27 作者: 笨拙處理 時(shí)間: 2025-3-22 22:54 作者: Veneer 時(shí)間: 2025-3-23 02:37
Circulating Tumor Cells: Applications for Early Breast Cancer,e intent. Despite this, some patients will relapse. The identification of patients at high risk remains an important challenge. CTCs can be useful to identify this patients, to assess tumor dynamics and to monitoring therapy. There is definitive evidence on the prognostic role of CTCs in early breas作者: Granular 時(shí)間: 2025-3-23 08:04 作者: 帳單 時(shí)間: 2025-3-23 11:47
Regulatorische Erfassung des Kreditrisikosn pattern and changes in the expression profile of noncoding RNAs. Here we summarize the recent findings on the epigenetic characterization of CTCs in breast cancer and their clinical value as tumor biomarkers, and discuss challenges and opportunities in this field.作者: 吸引人的花招 時(shí)間: 2025-3-23 14:49
Franz-Xaver Reichl,Michael Schwenkmeration of CTCs is variable among different tumors and is subjected to biases related mainly to their methodology, which is not completely standardized. In addition, they must demonstrate their clinical value to guide the treatment and a translation on patient’s survival.作者: 方便 時(shí)間: 2025-3-23 19:42
Epigenetics of Circulating Tumor Cells in Breast Cancer,n pattern and changes in the expression profile of noncoding RNAs. Here we summarize the recent findings on the epigenetic characterization of CTCs in breast cancer and their clinical value as tumor biomarkers, and discuss challenges and opportunities in this field.作者: cavity 時(shí)間: 2025-3-23 23:11
Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer,meration of CTCs is variable among different tumors and is subjected to biases related mainly to their methodology, which is not completely standardized. In addition, they must demonstrate their clinical value to guide the treatment and a translation on patient’s survival.作者: 現(xiàn)任者 時(shí)間: 2025-3-24 04:45
0065-2598 knowledge about the role of CTCs in breast cancer provided bThis book is aimed to summarise the key aspects of the role of circulating tumour cells (CTCs) in breast cancer, with special attention to their contribution to tumour progression and establishment of metastatic disease. We aim to give a cl作者: 分開如此和諧 時(shí)間: 2025-3-24 08:11 作者: Genteel 時(shí)間: 2025-3-24 12:40
Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for cular level and discuss the possible contribute of single cell analyses in precision medicine. We conclude with some remarks about the steps still necessary to achieve clinical validity and utility when considering also CTC phenotypic and molecular heterogeneity beyond a simple enumeration.作者: 吹氣 時(shí)間: 2025-3-24 16:00
Book 2020ibution to tumour progression and establishment of metastatic disease. We aim to give a clear overview of the knowledge about CTCs, framed in the context of breast cancer, by analysing basic and clinical research carried out so far. In a broader sense, we will address what are the main clinical need作者: 時(shí)代 時(shí)間: 2025-3-24 22:22 作者: 特征 時(shí)間: 2025-3-25 01:01 作者: 變化無常 時(shí)間: 2025-3-25 05:29
,Introduction?– Biology of Breast Cancer Metastasis and Importance of the Analysis of CTCs,lyses may have in the clinic. However, their implementation in routine clinic has not been yet achieved due to the yet small body of evidence showing their clinical utility. This introductory chapter will revise the key aspects of breast cancer metastasis and discuss the importance of CTC analyses in the management of breast cancer patients.作者: 疾馳 時(shí)間: 2025-3-25 10:17 作者: Intractable 時(shí)間: 2025-3-25 13:48 作者: Panther 時(shí)間: 2025-3-25 17:50
https://doi.org/10.1007/978-3-662-66215-1cular level and discuss the possible contribute of single cell analyses in precision medicine. We conclude with some remarks about the steps still necessary to achieve clinical validity and utility when considering also CTC phenotypic and molecular heterogeneity beyond a simple enumeration.作者: 暖昧關(guān)系 時(shí)間: 2025-3-25 23:09 作者: 商店街 時(shí)間: 2025-3-26 02:15
https://doi.org/10.1007/978-3-662-66215-1his chapter we will focus on the most relevant technologies for CTC isolation based on their properties and depending on whether it is a positive or negative selection. We also describe each technology based on its potential use and its relevance in breast cancer. The chapter also contains a future 作者: COKE 時(shí)間: 2025-3-26 07:52 作者: 我還要背著他 時(shí)間: 2025-3-26 10:27
https://doi.org/10.1007/978-3-322-92960-0gies for detection of CTCs and CTC clusters. However, more efficient methods are needed in order to address important questions regarding the metastatic potential of CTC and future clinical applications. In this chapter, we explore the current knowledge on the role of CTC clusters in breast cancer m作者: 孤僻 時(shí)間: 2025-3-26 15:08
Franz-Xaver Reichl,Michael Schwenko provide complementary information on the interplay of tumor cells with the immune system. The combination of different methods to detect tumoral disease by liquid biopsy may provide new ways to personalize in an unprecedented manner the management of patients with eBC.作者: epicondylitis 時(shí)間: 2025-3-26 18:04 作者: 故意釣到白楊 時(shí)間: 2025-3-26 21:06 作者: Odyssey 時(shí)間: 2025-3-27 01:50 作者: 推崇 時(shí)間: 2025-3-27 07:34
Circulating Tumor Cells: Applications for Early Breast Cancer,o provide complementary information on the interplay of tumor cells with the immune system. The combination of different methods to detect tumoral disease by liquid biopsy may provide new ways to personalize in an unprecedented manner the management of patients with eBC.作者: 含糊 時(shí)間: 2025-3-27 12:04
Book 2020l mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon 作者: Indigence 時(shí)間: 2025-3-27 16:49 作者: 柏樹 時(shí)間: 2025-3-27 19:36 作者: DIKE 時(shí)間: 2025-3-27 22:17
https://doi.org/10.1007/978-3-663-11289-1s of metastasis. They exhibit dynamic oscillations in epithelial to mesenchymal plasticity and provide important opportunities for prognosis, therapy response monitoring, and targeting of metastatic disease. In this manuscript, we review the involvement of epithelial-mesenchymal plasticity in the ea作者: 逃避責(zé)任 時(shí)間: 2025-3-28 02:26 作者: Rodent 時(shí)間: 2025-3-28 08:51
https://doi.org/10.1007/978-3-662-66215-1ast cancer mortality. Currently, liquid biopsies are gaining attention in this regard. Circulating tumor cells (CTCs), an important component of liquid biopsies, are cells shed from primary tumor that disseminate to blood circulation being responsible of distal metastasis. Hence, the study CTCs is a作者: urethritis 時(shí)間: 2025-3-28 12:47
https://doi.org/10.1007/978-3-662-66215-1nt blood samples sequentially over time and thereby serve as surrogates to assess the biology of surviving cancer cells that may still persist in solitary or multiple metastatic sites following treatment. CTCs may thus function as potential real-time decision-making guides for selecting appropriate 作者: 減至最低 時(shí)間: 2025-3-28 16:16 作者: 手勢(shì) 時(shí)間: 2025-3-28 20:01
https://doi.org/10.1007/978-3-322-92960-0n are not well established yet. The study of circulating tumour cells (CTCs), the metastatic precursors of distant disease, may help in this search. CTCs can be found in the blood of cancer patients as single cells or as tumor cell aggregates, known as CTC clusters. CTC clusters have differential bi作者: Diverticulitis 時(shí)間: 2025-3-29 01:23 作者: 出價(jià) 時(shí)間: 2025-3-29 04:38
Franz-Xaver Reichl,Michael Schwenke intent. Despite this, some patients will relapse. The identification of patients at high risk remains an important challenge. CTCs can be useful to identify this patients, to assess tumor dynamics and to monitoring therapy. There is definitive evidence on the prognostic role of CTCs in early breas作者: 不能仁慈 時(shí)間: 2025-3-29 08:39 作者: 著名 時(shí)間: 2025-3-29 12:52 作者: 愛好 時(shí)間: 2025-3-29 18:50 作者: 廚師 時(shí)間: 2025-3-29 21:37
Circulating Tumor Cells in Breast Cancer Metastatic Disease978-3-030-35805-1Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 上腭 時(shí)間: 2025-3-30 02:39 作者: 失眠癥 時(shí)間: 2025-3-30 05:30
978-3-030-35807-5Springer Nature Switzerland AG 2020
